 Partnership
July 9, 2024
In a significant development for the business and technology consulting industry, VCI Global Limited and Cogia AG have joined forces to establish a strategic joint venture. VCI Global, a leading provider of innovative business consulting services, has teamed up with Cogia AG, a renowned German technology company spe...
|
Product Service News
July 9, 2024
Teledyne DALSA Introduces High-Speed, High-Resolution Color Contact Image Sensors Amid Mixed Financial Performance WATERLOO, Canada, July 9, 2024 Teledyne DALSA, a global leader in high-performance digital imaging technology, proudly announces the expansion of its AxCIS family of Contact Image Sensors (CIS) with t...
|
Financing Agreement
July 9, 2024
Terawulf Inc, a leading player in the energy infrastructure industry, has announced a debt-free balance sheet, positioning the company for rapid scaling and deployment of highly sought-after energy infrastructure. Despite a net increase in borrowings during the first quarter of 2024, Terawulf Inc managed to enh...
|
|
 Contract
July 9, 2024
In an exciting development within the pharmaceutical industry, ReShape Lifesciences has announced the signing of a definitive merger agreement with Vyome Therapeutics, a clinical stage specialty pharmaceutical company focused on tackling immuno-inflammatory diseases with unmet medical need. This significant merger a...
 Product Service News
July 9, 2024
Introducing The Attendant: The Ultimate Smart Pool Automation for Latham Fiberglass PoolsThe pool industry is taking a leap into the future with the collaborative efforts of Latham Group, Inc. and Poolside Tech. This powerful partnership has resulted in the creation of The Attendant, a revolutionary smart pool autom...
|
|
Our most Popular Articles
|
Announcement
October 28, 2025
Empowering Young Minds: A Strategic Investment in Future Leaders In the rapidly evolving global landscape, where issues like democratic backsliding present ever-looming challenges, fostering the growth of informed, conscientious leaders has never been more crucial. Recognizing the urgent need to cultivate a generati...
|
Clinical Study
August 22, 2024
Sutro Biopharma Initiates REFRME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer SOUTH SAN FRANCISCO, Calif. Aug. 22, 2024 Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a leading clinical-stage oncology company specializing in site-specific and novel-format antibody drug co...
|
Business Update
April 23, 2024
Momentus Inc. (NASDAQ: MNTS), a prominent U.S. commercial space company specializing in satellite buses, transportation, and other in-space infrastructure services, has recently received a deficiency notification from the Nasdaq Capital Market LLC (Nasdaq) regarding its delayed Form 10-K filing. The Notice highlight...
|
|
|
Company News
|
Product Service News
July 9, 2024
Teledyne DALSA Introduces High-Speed, High-Resolution Color Contact Image Sensors Amid Mixed Financial Performance WATERLOO, Canada, July 9, 2024 Teledyne DALSA, a global leader in high-performance digital imaging technology, proudly announces the expansion of its AxCIS family of Contact Image Sensors (CIS) with t...
|
Financing Agreement
July 9, 2024
Terawulf Inc, a leading player in the energy infrastructure industry, has announced a debt-free balance sheet, positioning the company for rapid scaling and deployment of highly sought-after energy infrastructure. Despite a net increase in borrowings during the first quarter of 2024, Terawulf Inc managed to enh...
|
Clinical Study
July 9, 2024
AEON Biopharma Shifts Strategic Focus: Pioneers Biosimilar Pathway for ABP-450 with Proactive Phase 3 Trials and Promising Results AEON Biopharma is set to recalibrate its strategic direction toward developing biosimilars with a focused effort on ABP-450 through a 351(k) pathway. Scheduled to initiate a head-to-hea...
|
|
|
Company News
 Product Service News
July 9, 2024
|
Company News
 Product Service News
July 9, 2024
|
Company News
Clinical Study
July 9, 2024
|
More Company News
|
Clinical Study
July 9, 2024
|
Management Announcement
July 9, 2024
|
Management Announcement
July 9, 2024
|
Business Update
July 9, 2024
|
Partnership
July 9, 2024
|
Product Service News
July 9, 2024
|
Product Service News
July 9, 2024
|
Management Announcement
July 9, 2024
|
Partnership
July 9, 2024
|
Clinical Study
July 9, 2024
|
|
|
|
Related News
|
Contract
|
Clinical Study
|
|
Stocks
|
Product Service News
|
Product Service News
|
Clinical Study
|
|
|
|
Business News
|
 Contract
In an exciting development within the pharmaceutical industry, ReShape Lifesciences has announced the signing of a definitive merger agreement with Vyome Therapeutics, a clinical stage specialty pharmaceutical company focused on tackling immuno-inflammatory diseases with unmet medical need. This significant merger a...
|
|
Product Service News
Introducing The Attendant: The Ultimate Smart Pool Automation for Latham Fiberglass PoolsThe pool industry is taking a leap into the future with the collaborative efforts of Latham Group, Inc. and Poolside Tech. This powerful partnership has resulted in the creation of The Attendant, a revolutionary smart pool autom...
|
 Clinical Study
Microbot Medical, an innovative medical technology company, is making significant progress in its pivotal human clinical trial. The recent partnership with Baptist Hospital of Miami and Brigham and Women s Hospital demonstrates the company s commitment to advancing healthcare through groundbreaking research and deve...
|
 Partnership
Ocean Power Technologies Collaborates with AltaSea and Red Cat to Propel Blue Economy and Maritime Security Ocean Power Technologies (OPT) Embarks on Transformative Collaborations to Propel Blue Economy and Maritime Security Ocean Power Technologies (OPT), an industry pioneer in innovative ocean energy solutions, h...
|
 Partnership
In a significant development for the business and technology consulting industry, VCI Global Limited and Cogia AG have joined forces to establish a strategic joint venture. VCI Global, a leading provider of innovative business consulting services, has teamed up with Cogia AG, a renowned German technology company spe...
|
Our Most Popular Articles
|
 Announcement
Empowering Young Minds: A Strategic Investment in Future Leaders In the rapidly evolving global landscape, where issues like democratic backsliding present ever-looming challenges, fostering the growth of informed, conscientious leaders has never been more crucial. Recognizing the urgent need to cultivate a generati...
|
 Clinical Study
Sutro Biopharma Initiates REFRME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer SOUTH SAN FRANCISCO, Calif. Aug. 22, 2024 Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a leading clinical-stage oncology company specializing in site-specific and novel-format antibody drug co...
|
 Business Update
Momentus Inc. (NASDAQ: MNTS), a prominent U.S. commercial space company specializing in satellite buses, transportation, and other in-space infrastructure services, has recently received a deficiency notification from the Nasdaq Capital Market LLC (Nasdaq) regarding its delayed Form 10-K filing. The Notice highlight...
|
More News
|
 Product Service News
Teledyne DALSA Introduces High-Speed, High-Resolution Color Contact Image Sensors Amid Mixed Financial Performance WATERLOO, Canada, July 9, 2024 Teledyne DALSA, a global leader in high-performance digital imaging technology, proudly announces the expansion of its AxCIS family of Contact Image Sensors (CIS) with t...
|
 Financing Agreement
Terawulf Inc, a leading player in the energy infrastructure industry, has announced a debt-free balance sheet, positioning the company for rapid scaling and deployment of highly sought-after energy infrastructure. Despite a net increase in borrowings during the first quarter of 2024, Terawulf Inc managed to enh...
|
 Clinical Study
AEON Biopharma Shifts Strategic Focus: Pioneers Biosimilar Pathway for ABP-450 with Proactive Phase 3 Trials and Promising Results AEON Biopharma is set to recalibrate its strategic direction toward developing biosimilars with a focused effort on ABP-450 through a 351(k) pathway. Scheduled to initiate a head-to-hea...
|
 Product Service News
Link to article: SAI.TECH Announces MOU Signings for HEATNUC Targeting Nuclear and SMR Markets in the Middle East(source)In a recent development, SAI.TECH Global Corporation (SAI.TECH or SAI or the Company), a leading player in the small modular reactor (SMR) industry, has unveiled its strategic move to bolster its ...
|
|
Product Service News
Caribou Biosciences, Inc. (Nasdaq: CRBU), a pioneering clinical-stage biopharmaceutical company specializing in CRISPR genome-editing, has announced the appointment of Dr. Terri Laufer to its esteemed scientific advisory board. This strategic addition reflects Caribou Biosciences commitment to expanding its experti...
|
 Clinical Study
CSIMarket.com is pleased to present a groundbreaking article that highlights the recent European patent grant covering the use of brilaroxazine for the treatment of pulmonary hypertension (PH). This patent encompasses the treatment of not only PH but also pulmonary arterial hypertension (PAH) in all patients, incl...
|
 Clinical Study
Sjögren s Disease is a chronic autoimmune disorder characterized by dryness of the eyes and mouth due to the immune system attacking the moisture-producing glands. It affects millions of people worldwide, predominantly women, and currently, there are limited treatment options available for managing its symptoms eff...
|
 Management Announcement
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
Annovis Bio Inc., a late-stage clinical drug platform company specializing in transformative therapies for neurodegenerative disorders such as Alzheimer s Disease (AD) and Parkinson s Disease (PD), is pleased to announce the addition of four...
|
 Management Announcement
Safe Harbor Financial Successfully Recovers $3.1 Million Loan in Default, Garnering 100% Principal and $200,000 as Accrued Interest
Safe Harbor Financial (NASDAQ: SHFS) recently announced its achievement of successfully exiting a $3.1 million loan that had previously been in default. This accomplishment highligh...
|
 Business Update
Harrow Joins Apexus 340B Prime Vendor Program to Expand Access to IHEEZO and Other Essential Eyecare ProductsNASHVILLE, Tenn. - Harrow, a prominent eyecare pharmaceutical company in North America, has officially partnered with Apexus, a leading organization in the healthcare industry, to include their innovative pr...
|
|
Partnership
In a groundbreaking move set to potentially revolutionize the landscape of oncology, Prelude Therapeutics has announced a collaborative clinical initiative with Merck to evaluate the efficacy of its leading-edge molecule, PRT3789, in combination with Merck s renowned anti-PD-1 therapy, KEYTRUDA (pembrolizumab). This...
|
 Product Service News
Opthea Announces Promising Findings on VEGF-C and D Signaling Pathways, A Key Milestone in Wet AMD Treatment DevelopmentOpthea, a leading biopharmaceutical company focused on developing innovative therapies for eye diseases, has recently published groundbreaking research on the VEGF-C and D signaling pathways. These...
|
 Product Service News
Amesite, a leading artificial intelligence (AI) company, has recently reported an astonishing 93% accuracy rate of their NurseMagicApp in answering NCLEX model questions. This result highlights the effectiveness and reliability of the proprietary model integrated within NurseMagic, providing nurses with accurate results spanning from patient care environment to clinical judgment.Furthermore, NurseMagicApp has witnessed an exponential surge in user growth, with registered users surpassing a remarkable number of 1,100 in just one week of unrestricted public access to the app. This rapid increase in user adoption reflects the remarkable impact and relevance of the NurseMagicApp within the nursing community.
|
 Management Announcement
In a bid to revitalize its financial health and position itself for long-term success, Emergent BioSolutions Inc. has embarked on a multi-year transformation plan. The company, a leading player in the healthcare sector, has made significant strides in advancing its operational efficiency, reducing costs, and ge...
|
 Partnership
In a rapidly evolving business landscape, companies continue adapting through strategic partnerships, innovative product launches, and consistent growth efforts. Two companies making noteworthy strides are Symbeo and CorVel Corporation. Symbeo, a pioneer in accounts payable (AP) automation solutions, has broadened i...
|
 Clinical Study
Huntington s disease is a rare, inherited neurodegenerative disorder that causes the progressive deterioration of nerve cells in the brain, leading to motor, cognitive, and psychiatric symptoms. Unfortunately, there is currently no cure for this debilitating condition, making uniQure s AMT-130 gene therapy a potenti...
|
|
|
|
|
